|
WO0177361A1
|
|
Human immunoglobulin-producing gnotobiotics
|
|
WO0033788A2
|
|
Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
|
|
EP1098650A1
|
|
Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof
|
|
AU4578699A
|
|
Alpha-fluoro alkynoic acids with anticonvulsant activity
|
|
AU4701399A
|
|
2-fluoro-2-alkyl alkanoamides with anticonvulsant activity
|
|
MXPA00012808A
|
|
The use of valproic acid analog for the treatment and prevention of migraine and affective illness.
|
|
US6080384A
|
|
Methods for radionuclide-labeling of biomolecules and kits utilizing the same
|
|
CA1340013C
|
|
Method for the production of monoclonal antibodies utilizing a germfree animal
|
|
AU6398596A
|
|
Method of producing fibrin-specific antibodies using soluble fibrin polymers as an immunogen
|
|
WO9640986A1
|
|
Calibrator for use in a soluble fibrin assay
|
|
US6300373B1
|
|
Antiproliferative and neurotrophic molecules
|
|
US5672746A
|
|
Antiproliferative and neurotrophic molecules
|
|
US5487892A
|
|
Method for treating thrombotic disease using a fibrin specific monoclonal antibody
|
|
US5428635A
|
|
Multi-wavelength tunable laser
|
|
US5418804A
|
|
Controlled spectrum generation laser
|
|
US5418805A
|
|
Device for pumping the active medium of a white light laser
|
|
US5418803A
|
|
White light laser technology
|
|
US5453359A
|
|
Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
|
|
US5223410A
|
|
Method for production of antibodies utilizing an antigen-free animal
|
|
US5294548A
|
|
Recombianant Hepatitis a virus
|
